Rheuma Gen announced it raised $4.91 Million in an initial filing from an offering of $15 Million
04/17/24, 5:04 PM
Location
denverMoney raised
$4.91 million
Industry
biotechnology
Round Type
seed
Company Info
Location
200 quebec st.
denver, colorado, united states
Additional Info
RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases. RheumaGen focuses on editing the human leukocyte antigen (HLA), or "immune gene," to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado.